Stocks and Investing Stocks and Investing
Thu, November 9, 2023

Ami Fadia Maintained (AVDL) at Strong Buy with Increased Target to $19 on, Nov 9th, 2023


Published on 2024-10-28 07:27:53 - WOPRAI, Ami Fadia
  Print publication without navigation


Ami Fadia of Needham, Maintained "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy with Increased Target from $18 to $19 on, Nov 9th, 2023.

Ami has made no other calls on AVDL in the last 4 months.



There are 2 other peers that have a rating on AVDL. Out of the 2 peers that are also analyzing AVDL, 0 agree with Ami's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Ami


  • David Amsellem of "Piper Sandler" Maintained at Buy with Increased Target to $18 on, Thursday, August 10th, 2023
  • Oren Livnat of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $21 on, Thursday, August 10th, 2023

Contributing Sources